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Introduction: 
 An essential component of cellular function is the integration of numerous signals to 
generate a single response. For example, every cell receives multiple intrinsic and extrinsic cues 
that influence whether or not it will survive or undergo the process of programmed cell death, 
known as apoptosis. In short, alterations in signaling may influence cell fate. The question then 
arises: What signals tip the balance towards cell death as opposed to cell survival? We are 
interested in the role of the microtubule cytoskeleton and its accessory proteins in the survival of 
cancer cells. Thus, we have narrowed this question to ask what is the role of microtubule 
regulatory proteins in tipping the balance toward cancer cell death?  
Microtubules are hollow filaments approximately 25nm in diameter that are composed of 
α/β-tubulin heterodimers (2). During microtubule nucleation, α/β-tubulin heterodimers 
polymerize in a polarized fashion and form linear chains known as protofilaments (2). Thirteen 
protofilaments arrange in parallel to form sheets that are held together by non-covalent lateral 
and longitudinal bonds (2). These sheets subsequently circularize to complete the tube-like 
structure (2). An important component of microtubule nucleation is the γ-tubulin ring complex 
(2). The γ-tubulin ring complex has a helical pitch that matches that of a microtubule (2). 
Further, the γ-tubulin ring complex binds the α-tubulin face of a α/β-tubulin heterodimer to 
initiate microtubule nucleation (2). As a result, the localization of γ-tubulin ring complexes 
spatially controls microtubule nucleation (9).  
The site at which microtubule polymerization occurs is known as a microtubule-
organizing center (9). The main microtubule-organizing center in a cell is the centrosome (9). 
The centrosome is composed of two centrioles and is surrounded by the pericentriolar matrix, 
which contains proteins that specialize in γ-tubulin recruitment (9). Microtubules that arise from 
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the centrosome radiate outwards towards the cell periphery, and are essential in the formation of 
the mitotic spindle (9). Thus, microtubules play a pivotal role in cell division. 
Many frequently used chemotherapy drugs, such as paclitaxel and vinblastine, are 
thought to cause cell death by interrupting microtubule spindle formation and consequently 
activating a cell cycle checkpoint (1). Of recent interest are microtubule regulatory proteins, 
which may also provide useful targets for cancer therapy. The microtubule regulatory protein 
stathmin/Oncoprotein 18 is overexpressed in many highly malignant cancers such as leukemia, 
lymphoma, prostrate cancer, and breast cancer (1). Stathmin sequesters free α/β-tubulin 
heterodimers and promotes depolymerization (2). There is evidence that stathmin is specifically 
required for the survival of p53-deficient cells (1). Notably, p53 is a tumor suppressor gene that 
is deficient in over 50% of cancer cells (1). The primary role of p53 is to temporarily halt cell 
proliferation or activate apoptosis in response to DNA damage (2). Cells lacking p53 are less 
efficient at repairing damaged DNA and activating apoptosis in the event that the damage is 
beyond repair (2). Depletion of stathmin in p53-deficient cells results in a ~4 hour delay in 
mitotic entry and ultimately increases the amount of cell death via activation of the extrinsic 
apoptotic pathway (11; 12) (Figure 2A).  
With regards to the delay in mitotic entry, there is evidence that stathmin regulates 
mitotic entry in part by controlling the activation and localization of the mitotic enzymes Aurora 
A Kinase (AURKA) and Plk1 (11). AURKA and Plk1 have been shown to regulate microtubule 
nucleation and assembly on centrosomes (11). Both enzymes are involved in a positive feedback 
loop with CDC25 that results in the activation of CDK1/cyclin B (11). Sufficient activation of 
CDK1/cyclin B allows cells to overcome the restriction point in the cell cycle and ensures 
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commitment to mitosis (2). Stathmin depletion delays localization of AURKA and Plk1 to the 
centrosome and subsequently inhibits their activation (11).  
With regards to cell death, p53-deficient cells exhibit low expression of cFLIP, a protein 
that blocks caspase-8 activation (12). The level of cFLIP is further reduced by stathmin depletion 
(12). This ultimately results in the activation of caspase 8 (12). Activated caspase 8 ultimately 
increases the cells’ propensity towards death via the extrinsic apoptotic pathway (12).  
Despite much advancement, there is still a lot that is unknown regarding the phenotype of 
stathmin depleted p53-deficient cells. The following models propose mechanisms for the delayed 
mitotic entry and increase in cell death, respectively.  
The first proposed model addresses the delay in mitotic entry. This model links 
microtubule regulation and the Golgi apparatus. The Golgi apparatus is a critical component in 
the eukaryotic secretory pathway and is essential for the sorting and packaging of newly formed 
proteins (13). Notably, the Golgi apparatus is composed of multiple flattened, membrane bound 
structures known as cisternae, which are organized into parallel arrays to form individual stack 
structures (13). In eukaryotic cells, multiples of these stack structures are linked together to form 
a continual membrane known as the Golgi ribbon, which is localized adjacent to the centrosome 
(13). Recently, it has been found that the components in the pericentriolar matrix that recruit γ-
tubulin to the centrosome also recruit γ-tubulin to the Golgi apparatus (10). For example, it has 
been shown that AKAP450, a γ-tubulin ring complex interacting protein that is localized at the 
centrosome, recruits γ-tubulin to the Golgi by binding to the cis-Golgi matrix protein GM130 
(10). As a result, there is now evidence that the Golgi apparatus is a site of microtubule 
nucleation (10). Like for the centrosome, it has been demonstrated that Golgi nucleated 
microtubules are anchored by dynein and dynactin protein complexes (10). It has since been 
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suggested that Golgi nucleated microtubules are essential for maintaining the integrity of the 
ribbon structure (9). Importantly, in vertebrates, fragmentation of the Golgi ribbon prior to 
mitotic entry is essential to promote equal distribution of the Golgi between daughter cells (4). 
During this process, the Golgi ribbon is unlinked into individual subunits, and subsequently 
unstacked into individual cisternae (9). Following cytokinesis, the cisternae reassemble into a 
continual ribbon structure (9). Research has shown that blocking the unlinking of the Golgi 
ribbon in G2 causes a delay in mitotic entry (14). Further, there is evidence that blocking Golgi 
dispersal impairs the localization and activation of AURKA at the centrosome (7). We suggest 
that stathmin regulates microtubules at the Golgi, as well as the centrosome. Following this 
postulation, we predict that stathmin depletion stabilizes Golgi nucleated microtubules, thus 
preventing Golgi dispersal and delaying mitotic entry (Figure 1A).  
To address the proposed model we first raise the question, does stathmin depletion in 
p53-deficient cells effect dispersal of the Golgi apparatus? In order to examine this question, we 
have utilized an artificial assay to trigger Golgi dispersal in stathmin depleted p53-deficient cells. 
We hypothesized that stathmin depletion stabilizes Golgi nucleated microtubules and ultimately 
slows Golgi fragmentation and dispersal. 
The second proposed model addresses the increase in cell death. This model links 
microtubule regulation to a signal transduction pathway. It has been suggested that stathmin is 
involved in a negative feedback loop with c-Jun N-terminal kinase (JNK) (15). Specifically, 
oxidative stress, and the resulting accumulation of reactive oxygen species, triggers the 
phosphorylation of MKK-4, which in turn activates JNK through a phosphorylation event (15). 
Active JNK subsequently inactivates stathmin by phosphorylation at Ser-16, Ser-25, and Ser-38. 
Phosphorylated stathmin in turn inhibits the activation of MKK-4 (15). This negative feedback 
	 6	
loop promotes cell survival (15). Without this feedback loop, there is prolonged activation of 
JNK, which stimulates apoptosis (15). One way that active JNK has been shown to induce 
apoptosis is by increasing the degradation of cellular FLICE-like inhibitory protein (c-FLIP) (3). 
Specifically, active JNK activates the E3 ubiquitin ligase ITCH by phosphorylation (3). 
Activated ITCH subsequently ubiquitinates c-FLIP, thus triggering proteasomal degradation of 
c-FLIP (3). Degradation of c-FLIP promotes cleavage of pro-caspase-8 to form active caspase-8 
(2). This results in the initiation of the extrinsic apoptotic pathway (2). As previously mentioned, 
stathmin depleted p53-deficient cells have significantly reduced levels of c-FLIP, which is in part 
responsible for the increase in cell death seen via the extrinsic apoptotic pathway (13). We 
suggest that stathmin depletion in p53-deficient cells results in prolonged activation of JNK, 
which in turn activates ITCH causing the degradation of c-FLIP and cell death via caspase-8 
(Figure 2B).  
To address this proposed model we examined the effect of stathmin and ITCH double 
depletion in p53-deficient cells. We hypothesized that depletion of ITCH in stathmin depleted 
cells restores cell viability. Specifically, if stathmin depletion increases ITCH activation but 
ITCH is depleted, than there will be minimal ITCH activity. Thus, there should be less c-FLIP 
degradation and less death via the extrinsic apoptotic pathway. 
Overall, this work seeks to identify the mechanisms by which stathmin depletion in p53-
deficient cells leads to delayed mitotic entry and cell death by testing the models outlined above. 
Doing so may play a pivotal role in identifying stathmin as a potential therapeutic target.  
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Materials/Methods: 
Cell Culture:  
Hela cells were grown and maintained at 37°C in a humidified environment consisting of 
5% CO2. The media used to culture these cells was DMEM (Sigma-Aldrich) supplemented with 
1x antibiotic/antimycotic (Sigma-Aldrich) and 10% fetal bovine serum (Invitrogen). 
 
siRNA Transfection: 
 Hela cells were grown in 35mm dishes. The transfection procedure was completed using 
GeneSilencer Transfection Reagents (Genlantis) by following the manufacturer’s instructions. A 
solution of GeneSilencer reagent and serum free media was mixed for five minutes. A second 
solution of siRNA diluent, serum free media, and the desired siRNA was also mixed for five 
minutes. The solutions were then combined and mixed for five minutes. The cells’ media was 
replaced with serum free medium to increase transfection efficiency. Following the addition of 
the transfection solution, the cells were incubated at 37°C in a humidified environment 
consisting of 5% CO2. After 4 hours of incubation, the media was supplemented with serum and 
the cells were incubated for an additional 48 hours. The following are the siRNA 
oligonucleotides used throughout the experiments: stathmin1 siRNA 5’-
CCCAGUUGAUUGUGCAGAAUU-3’ (Thermo Scientific/ Dharmacon) and ITCH siRNA 5’- 
GAAACUACAUGUUCAGAAA-3’ (Thermo Scientific/Dharmacon). 
 
Doxorubicin Treatment: 
 Doxorubicin is a known DNA damaging agent. It has been shown that treatment of Hela 
cells with doxorubicin triggers dispersal of the Golgi apparatus (6). In experiments requiring 
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Golgi dispersal, cells were treated with 25nM of doxorubicin. For knockdown groups, 
doxorubicin was added 24 hours after the addition of siRNA. Following the addition of 
doxorubicin, cells were incubated for 24 hours at 37°C in a humidified environment consisting of 
5% CO2. 
 
Immunofluorescence: 
Cells were grown on glass coverslips and fixed in -20°C methanol and EDTA (1:200) for 
10 minutes. The cells were then rehydrated in PBS and blocked in a phosphate buffered saline 
(PBS) and fetal bovine serum (FBS; 1:10) for 30 minutes at 37°C. Following block, the cells 
were incubated with primary antibodies for 45 minutes at 37°C then washed three times in PBS 
for five-minutes each. This was followed by 45 minutes of incubation with secondary antibodies 
at 37°C and an additional three five-minutes washes in PBS. Coverslips were mounted onto glass 
slides using Vectashield (Vector Laboratories). The following is a list of primary antibodies used 
throughout the experiments: mouse anti-GM130 (1:50; Sigma-Aldrich) to label the Golgi 
apparatus, rabbit anti-α tubulin (1:100; Sigma-Aldrich) to label microtubules, mouse anti-
cleaved PARP (1:50; Sigma-Aldrich) as a marker of apoptosis. The following is a list of 
secondary antibodies used throughout the experiments: AlexaFluor GAR-488 (1:50; Gibco-
Invitrogen), AlexaFluor GAM-568 (1:50; Gibco-Invitrogen), and Propidium Iodide (1:1000; 
Gibco-Invitrogen) to label DNA. Cells were observed using the 40X objective on an inverted 
microscope (Nikon TE2000E). Images were acquired using the program MetaVue. For both 
Golgi dispersal experiments and cleaved PARP experiments at least 50 cells were examined for 
each group per experiment. Data for cleaved PARP experiments were normalized by setting the 
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percentage of cleaved PARP positive ITCH depleted cells equal to 1. Normalized data were 
pooled for cleaved PARP experiments.  
 
Measuring Relative Golgi Area and Statistical Analysis: 
Using immunofluorescent images, the relative area of the Golgi was measured. The 
relative area of the Golgi was manually traced using a selection tool on the program MetaVue. 
The region statistics provided by MetaVue were used to determine the relative Golgi area (6). 
Statistical analysis of the collected data was done using unpaired t-tests in Microsoft Excel.  
 
Western Blotting: 
Whole cell lysates were prepared using a lysis buffer composed of 2x Hepes/NaCl buffer, 
protease inhibitor, 200mM EDTA, 10% NP-40, 100mM DTT, 200mM PMSF, and dH2O. Cells 
were treated with the lysis buffer on ice for 30 min. Cells were then centrifuged at 13,000rpm for 
10 minutes at 4°C. The supernatant was then aspirated and the pellet was discarded. Protein 
concentrations were measured using a Bradford assay. Lysates were then diluted in SDS PAGE 
sample buffer and supplemented with β-mercaptoethanol. For each sample, 10μg total protein 
was loaded per lane and resolved in a 10% polyacrylamide gel. Proteins were then transferred to 
a PVDF membrane. After transfer, membranes were blocked with 5% nonfat milk in Tris-
buffered saline (TBS) with 0.1% Tween. Membranes were then probed using primary antibodies: 
anti-stathmin (1:2000; Sigma-Aldrich), anti- ITCH (1:1000; GE Healthcare), or anti-α tubulin 
B512 (1:1000; Sigma-Aldrich) as a loading control. Membranes were then probed using 
secondary antibodies: goat anti-mouse horseradish peroxidase (1:5000; Sigma- Aldrich) or goat 
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anti- rabbit horseradish peroxidase (1:5000; Sigma-Aldrich). Immunoreactive bands were 
developed using enhanced chemiluminscence (ECL) prime (GE Amersham). 
 
Results: 
Stathmin depletion in p53-deficient cells has an intermediate effect on Golgi dispersal: 
 It was hypothesized that stathmin depletion causes stabilization of Golgi nucleated 
microtubules. Therefore, Golgi dispersal was expected to be slower in stathmin depleted Hela 
cells compared to control cells. Stathmin depletion was achieved using a siRNA transfection and 
was confirmed by western blot (Figure 3B). Cells were then treated with the DNA damaging 
agent doxorubicin to trigger Golgi dispersal. DNA damage via doxorubicin results in the 
activation of DNA damage activated protein kinase (DNA-PK), which activates the peripheral 
Golgi protein GOLPH3 by phosphorylation (6). Activated GOLPH3 interacts with the myosin 
protein MYO18A, which causes actin and myosin interactions to increase the tensile force 
applied to the Golgi (6). This ultimately causes Golgi fragmentation (6).  
In this experimental design there were four conditions: 0 hour doxorubicin treated 
control, 24 hour doxorubicin treated control, 0 hour doxorubicin treated stathmin depleted, 24 
hour doxorubicin treated stathmin depleted. Immunofluorescence was used to label microtubules 
(anti-α tubulin) and the Golgi apparatus (anti-GM130) (Figure 3A). Microtubules were labeled 
in order to identify mitotic cells and the position of the centrosome (Figure 3A). The microtubule 
population was notably denser in stathmin depleted cells (Figure 3A). In untreated cells the 
Golgi apparatus had a concave shape and was located adjacent to the nucleus and centrosome 
(Figure 3A). However, in cells that were treated with doxorubicin the Golgi was fragmented and 
dispersed throughout the cytosol (Figure 3A). Importantly, the Golgi in doxorubicin treated cells 
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was noticeably more dispersed compared to the Golgi in untreated cells (Figure 3A). For each 
group, the relative Golgi area was manually traced with a selection tool on the program Metavue. 
The relative Golgi area was only recorded for cells in interphase.  
Data were collected for 594 untreated control cells, 472 untreated stathmin depleted cells, 
513 doxorubicin treated control cells, and 458 doxorubicin treated stathmin depleted cells total 
(Figure 4A & Figure 4B). Unpaired t-tests revealed that there was a significant difference (p-
value <0.05) between the doxorubicin treated stathmin depleted cells and the doxorubicin treated 
control cells, as well as between the untreated stathmin depleted cells and doxorubicin treated 
stathmin depleted cells (Figure 4A). For further comparison, the average relative Golgi area of 
the doxorubicin treated control group was considered to be representative of 100% dispersal. 
Using this as a baseline, the percentage of Golgi dispersal was calculated for the stathmin 
depleted cells. Doxorubicin treated stathmin depleted cells were on average 64% dispersed. This 
supports the idea that stathmin depletion in p53-deficient cells has an intermediate effect on 
Golgi dispersal. 
 
Preliminary evidence that stathmin depletion results in increased activity of ITCH: 
 Immunofluoresence was used to label DNA (propidium iodide) and cleaved PARP (anti-
cl-PARP) in Hela cells. During apoptosis, the executioner caspase, caspase 3, has the dual 
function of cleaving poly ADP ribose polymerase (PARP) and releasing caspase-dependent 
DNase (CAD) from its inhibitor iCAD. Active CAD enters the nucleus and works with cleaved 
PARP to degrade DNA and ultimately cause cell death (5). Thus, cleaved PARP was labeled as a 
marker for apoptosis (5).  
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In this experimental design there were four groups: untreated, stathmin depleted, ITCH 
depleted, and stathmin/ITCH depleted. Stathmin and ITCH depletion was achieved using siRNA 
transfections and was confirmed by western blot (Figure 5B). Cells that were positive for cleaved 
PARP were considered apoptotic. It was predicted that ITCH knockdown would restore cell 
viability in stathmin depleted cells. Therefore, it was expected that there would be a higher 
percentage of death among stathmin depleted cells compared to stathmin/ITCH double depleted 
cells.  
 Data were normalized against the percentage of cleaved PARP positive ITCH depleted 
cells and pooled for all experiments. We found a lower percentage of cleaved PARP positive 
cells in the stathmin/ITCH double depleted group compared the stathmin depleted group (Figure 
5A). This is preliminary evidence that ITCH knockdown restores cell viability in stathmin 
depleted cells.  
 
Discussion: 
 Stathmin is a microtubule destabilizing protein that is overexpressed in some highly 
malignant cancer cells (1). The role of stathmin in cancer cell fate has been documented within 
the literature. Specifically, stathmin depletion in p53-deficient cells causes a ~4 hour delay in 
mitotic entry and an increase in cell death via the extrinsic apoptotic pathway (11; 12). In this 
work we explored two independent models that we predicted were responsible for the delay in 
mitotic entry and increase in cell death, respectively.   
 The first model suggested that stathmin acts on Golgi nucleated microtubules. We 
hypothesized that stathmin depletion would stabilize Golgi nucleated microtubules and slow 
Golgi dispersal, thus delaying mitotic entry. To test this model we triggered Golgi dispersal in 
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stathmin depleted p53-deficient cells. We demonstrated that there is a significant difference in 
Golgi dispersal between doxorubicin treated control cells and doxorubicin treated stathmin 
depleted cells. Specifically, Golgi dispersal in doxorubicin treated stathmin depleted cells was 
approximately 64% that of control cells. This suggests that stathmin depletion has an 
intermediate effect on Golgi dispersal. Other work in the lab has shown that there is no 
significant change in the stability of Golgi microtubules in stathmin depleted p53-deficient cells 
compared to control cells (8). Therefore, we conclude that there is not strong evidence for 
stathmin depletion working via Golgi stabilization. It is possible that our finding is an artifact of 
a different pathway initiated by the doxorubicin treatment.  
 The second model suggested that stathmin depletion works through a negative feedback 
loop to promote cell death via the extrinsic apoptotic pathway. Our model suggests that stathmin 
depletion results in prolonged activation of JNK causing phosphorylation of the E3 ubiquitin 
ligase ITCH, and subsequent degradation of c-FLIP, a protein that blocks caspase 8 activation. 
Therefore, we predicted that stathmin depletion induces apoptosis by increasing the amount of 
activated ITCH. To test this model we labeled cleaved-PARP in stathmin/ITCH double depleted 
p53-deficient cells as a marker for apoptosis. We found preliminary evidence that ITCH 
knockdown restores cell viability in stathmin depleted p53-deficient cells. However, additional 
research is necessary to confirm this link. Future research will consist of additional cleaved 
PARP experiments and live-cell imaging to track cell death in stathmin/ITCH double depleted 
p53-deficient cells. It is also essential to confirm that stathmin depletion results in an increase in 
phosphorylated ITCH due to prolonged JNK activation. Confirmation of this signaling pathway 
would identify a specific mechanism by which stathmin depletion results in the activation of the 
extrinsic apoptotic pathway in p53-deficient cells. 
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 In conclusion, the link between microtubule regulation and decisions regarding cell fate 
is intricate. Evidence supports that stathmin has a unique role in promoting cell survival in some 
forms of cancer. It has been shown that stathmin depletion in p53-deficient cells delays mitotic 
entry and results in an increase in cell death (11; 12). In this work we have ruled out the 
possibility of stathmin depletion causing a delay in mitotic entry by slowing dispersal of the 
Golgi ribbon. Further, we have preliminary support for stathmin depletion causing an increase in 
cell death through a signal transduction pathway with ITCH. Identifying the specific mechanisms 
by which stathmin depletion effects p53-deficient cells continues to be an active area of research. 
Further characterization of stathmin can prove to be influential in the development of cancer 
therapies. 
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Figure 1: Known Phenotypes and Proposed Model for Cell Cycle Delay in Stathmin 
Depleted p53-Deficient Cells.  A. Normally, p53-deficient cells enter mitosis at some point in 
time. Mitotic entry is delayed by ~4 hours in stathmin depleted p53-deficient cells (11). 
Similarly, mitotic entry is delayed when Golgi dispersal is blocked (14). We propose that these 
two phenotypes are linked. We predict that stathmin depletion in p53-deficient cells stabilizes 
Golgi nucleated microtubules, thus slowing Golgi fragmentation and subsequently delaying 
mitotic entry. 
  
A. 
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Figure 2: A. Phenotype of Stathmin Depleted p53-Deficient Cells. In stathmin depleted p53-
deficient cells mitotic entry is delayed and there is an increase in cell death. B. Proposed Model 
for Increased Cell Death in Stathmin Depleted p53-deficient Cells. A positive trigger 
activates MKK4 through phosphorylation. Phosphorylated MKK4 activates JNK. JNK 
inactivates stathmin through phosphorylation. Phosphorylated stathmin is involved in a negative 
feedback loop that inhibits the activation of MKK4. We propose stathmin depletion results in 
prolonged activation of JNK, which in turn causes the activation of the E3 ubiquitin ligase ITCH. 
Activated ITCH subsequently ubiquinates c-FLIP, which causes its degradation. The degradation 
of c-FLIP promotes the activation of caspase 8 and cell death via the extrinsic apoptotic pathway.  
B. 
A. 
B. 
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Figure 3: A. Immunofluorescent Images of Microtubules and the Golgi Apparatus in Hela 
Cells. Microtubules were stained using the primary antibody rabbit anti-α tubulin (1:100) and the 
secondary antibody AlexaFluor GAR-488. The Golgi apparatus was stained using the primary 
antibody mouse anti-GM130 (1:50) and the secondary antibody AlexaFluor GAM-568 (1:50). In 
order from left to right the columns correspond to images of microtubules, the Golgi apparatus, 
and a color combination that overlays the two. From top to bottom the rows correspond to an 
untreated control group, a doxorubicin treated control group, an untreated stathmin depleted 
group, and a doxorubicin treated stathmin depleted group. Cells in the doxorubicin treated 
groups were treated with 25nM of doxorubicin for 24 hours. B. Western Blot. Western blot 
confirms successful knockdown of stathmin. Stathmin has a molecular weight of 18KDa. 
A. 
B. 
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Figure 4: A. Relative Golgi Area.  The relative Golgi area was measured by manually tracing 
the area of the Golgi using the program MetaVue. The results were plotted using the program 
Kaleidagraph. Statistical significance was determined using unpaired t-tests on Microsoft Excel. 
A p-value < 0.05 was considered significant. Statistical significance is indicated by a (*), which 
corresponds to a p-value < 0.001. The only relationship that was not statistically significant was 
between the untreated control group and the untreated stathmin depleted group where p= 0.058. 
B. Average Relative Golgi Area. Average relative Golgi area listed for each group. 
 
A. 
B. 
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Figure 5: A. Normalized Percentage of Cleaved-PARP Positive Cells. The nucleus was 
stained using propidium iodide (1:1000). Cleaved-PARP was stained using the primary antibody 
mouse anti-cleaved PARP (1:50) and the secondary antibody AlexaFluor GAM-568 (1:50). 
Cleaved-PARP positive cells were counted. This experiment was completed twice. Data were 
normalized and compiled. The results were graphed using Microsoft Excel. B. Western Blot. 
Western blot confirms successful knockdown of ITCH. ITCH has a molecular weight of 
103KDa. The blot was also probed for α-tubulin as a loading control. Tubulin has a molecular 
weight of 50KDa.  
  
A. 
B. 
	 20	
References  
1) Carney, B. K., & Cassimeris, L. (2010). Stathmin/Oncoprotein 18, A microtubule regulatory 
protein, is required for survival of both normal and cancer cell lines lacking the tumor 
suppressor, p53. Cancer Biology and Therapy, 9(9), 699-709. doi:10.4161/cbt.9.9.11430  
2) Cassimeris, L., Lingappa, V. R., & Plopper, G. (2010). Cells (Second ed.) Jones & Bartlett 
Learning.  
3) Chang, L., Kamata, H., Solinas, G., Luo, J., Maeda, S., Venuprasad, K., Liu, Y., & Karin, M. 
(2006). The E3 ubiquitin ligase itch couples JNK activation to TNFα- induced cell death by 
inducing c-FLIPL Turnover. Cell, 124(3), 601-613. doi:10.1016/j.cell.2006.01.021  
4) Colanzi, A., & Corda, D. (2007). Mitosis controls the golgi and the golgi controls mitosis. 
Current Opinion in Cell Biology, 19, 386-393. doi:10.1016/j.ceb.2007.06.002  
5) Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicology and Pathology, 
35(4), 495-516.  
6) Farber-Katz, S. E., Dippold, H. C., Buschman, M. D., Peterman, M. C., Xiang, M., Noakes, C. 
J., Tat, J., Ng, M. M., Rahajeng, J., Cowan, D. M., Fuchs, G. J., Zhou, H., & Field, S. J. 
(2014). DNA damage triggers golgi disperal via DNA-PK and GOLPH3. Cell, 156(3), 413-
427. doi:10.1016/j.cell.2013.12.023  
7) Persico, A., Cervigni, R. I., Barretta, M. L., Corda, D., & Colanzi, A. (2010). Golgi 
partitioning controls mitotic entry through aurora-A kinase. Molecular Biology of the Cell, 
21, 3708-3721. doi:10.1091/mbc.E10-03-0243  
	 21	
8) Peters, K., & Cassimeris, L. (Unpublished Lehigh University) 
9) Rios, R. M. (2014). The centrosome-- golgi apparatus nexus. Philisophical Transactions of the 
Royal Society, 369, 1-9.  
10) Rivero, S., Cardenas, J., Bornens, M., & Rios, R. M. (2009). Microtubule nucleation at the 
cis- side of the golgi apparatus requires AKAP450 and GM130. The EMBO Journal, 28(8), 
1016-1028. doi:10.1038/emboj.2009.47  
11) Silva, V. C., & Cassimeris, L. (2013). Stathmin and microtubules regulate mitotic entry in 
HeLa cells by controlling activation of both aurora kinase A and Plk1. Molecular Biology of 
the Cell, 24(24), 3919-3931. doi:10.1091/mbc.E13-02-0108  
12) Silva, V. C., Plooster, M., Leung, J. C., & Cassimeris, L. (2015). A delay prior to mitotic 
entry triggers caspase 8- dependent cell death in p53-deficient hela and HCT-116 cells. Cell 
Cycle, 14(7), 1070-1081. doi:10.1080/15384101.2015.1007781  
13) Sutterlin, C., & Colanzi, A. (2010). The golgi and the centrosome: Building a functional 
partnership. Journal of Cell Biology, 188(5), 621-628. doi:10.1083/jcb.200910001  
14) Sutterlin, C., Hsu, P., Mallabiabarrena, A., & Malhotra, V. (2002). Fragmentation and 
dispersal of the pericentriolar golgi complex is required for entry into mitosis in mammalian 
cells. Cell, 109(3), 359-369. doi:10.1016/S0092-8674(02)00720-1 
15) Zhao, E., Amir, M., Lin, Y., & Czaja, M. J. (2014). Stathmin mediates hepatocyte resistance 
to death from oxidative stress by down regulating JNK. PLoS One, 9(10), 1-12. 
doi:10.1371/journal.pone.0109750  
